John Lee

Title: Innovations by John Lee in Colorectal Cancer Therapy

Introduction

John Lee is an accomplished inventor based in Walnut Creek, CA (US). He has made significant contributions to the field of cancer therapy, particularly in colorectal cancer. With a total of 5 patents to his name, his work focuses on improving patient outcomes through innovative methods.

Latest Patents

One of John Lee's latest patents is a method of predicting response to therapy by assessing tumor genetic heterogeneity. This invention involves measuring tumor genetic heterogeneity through the analysis of circulating tumor DNA from a patient's sample. Another notable patent is a non-invasive test to predict the recurrence of colorectal cancer. This method also utilizes the analysis of circulating tumor DNA from a patient's sample to forecast potential recurrence following surgery.

Career Highlights

John Lee is currently employed at Roche Sequencing Solutions, Inc., where he continues to develop groundbreaking technologies in the field of oncology. His work is pivotal in advancing personalized medicine and improving therapeutic strategies for colorectal cancer patients.

Collaborations

Some of his coworkers include John Palma and Stephanie Yaung, who contribute to the innovative environment at Roche Sequencing Solutions, Inc. Their collaborative efforts enhance the research and development of new cancer therapies.

Conclusion

John Lee's contributions to cancer therapy through his innovative patents demonstrate his commitment to improving patient care. His work in predicting therapy responses and recurrence in colorectal cancer is paving the way for more effective treatment options.